Author

Gina Davis

Institution: Mercy Hospital

Observed institutions: United States Food and Drug Administration, University of California, San Francisco, Prince of Wales Hospital, Mercy Hospital, University of California, Davis

ORCID: 0009-0007-5652-4160

Observed ORCID: 0009-0007-5652-4160

OpenAlex ID: A5107310798

FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non–Small Cell Lung Cancer Following Crizotinib

2016 · Erin Larkins, Gideon M. Blumenthal, et al. · Clinical Cancer Research · 135

Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population

2012 · Erica B. Johnstone, Gina Davis, et al. · Gynecological Endocrinology · 21

Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management

2025 · Gina Davis, Dana Kim, et al. · Heart Lung and Circulation · 8

Patient willingness to participate in a clinical trial with preimplantation genetic diagnosis

2007 · Lora K. Shahine, Miriam Kuppermann, et al. · Fertility and Sterility · 7

Association Between Protein Content in Dry Dog Food and Aggression in Golden Retriever Dogs

2025 · Gina Davis, Julia Labadie, et al. · Journal of the American Animal Hospital Association · 3

Bio-resorbable poly-4-hydroxybutyrate (P4HB) mesh for abdominal wall reconstruction is effective in high-risk patients and contaminated abdomen

2025 · Anil K. Srivastava, Katherine A. Kummer, et al. · Hernia · 2

743: Comprehensive Strategy to Reduce Cautis in the Icu: a Quality Improvement Initiative

2026 · Vinaya Sermadevi, Kendra Kelly, et al. · Critical Care Medicine

Works count: 7

Citation count: 176

H-index: 4

I10-index: 2